Journey Medical (DERM) Capital Expenditures (2020 - 2023)

Journey Medical has reported Capital Expenditures for 3 years, with the latest figure at $5.0 million in Q1 2023.

• For the quarter ending Q1 2023, Capital Expenditures fell 75.0% year-over-year to $5.0 million; the trailing twelve-month figure through Dec 2023 stood at $5.0 million (down 75.0% YoY), and the FY2024 full-year result was $15.0 million, up 200.0% from the prior year.
• Capital Expenditures for Q1 2023 stood at $5.0 million, down from $20.0 million in the prior quarter.
• The five-year high for Capital Expenditures was $20.0 million in Q1 2022, with the low at $4.1 million in Q4 2020.
• Historically, Capital Expenditures has averaged $9.7 million across 3 years, with a median of $5.0 million in 2023.
• The largest YoY upside for Capital Expenditures was 75.0% in 2023 against a maximum downside of 75.0% in 2023.
• Journey Medical's Capital Expenditures stood at $4.1 million in 2020, then jumped by 382.51% to $20.0 million in 2022, then slumped by 75.0% to $5.0 million in 2023.
• The last three Capital Expenditures figures came in at $5.0 million (Q1 2023), $20.0 million (Q1 2022), and $4.1 million (Q4 2020), per Business Quant data.